Overview
The aim of this clinical trial is to compare the horizontal bone gain when grafting a bone substitute with non fixed resorbable collagen membranes (control group), versus fixed resorbable collagen membranes (test group) in resorbed ridges requiring Guided Bone Regeneration (GBR) to facilitate implant placement at 6 months.
Description
The aim of this clinical trial is to compare the horizontal bone gain when grafting a mixture of xenograft and allograft (50/50) with non fixed resorbable collagen membranes (control group), versus fixed resorbable collagen membranes (test group) in resorbed ridges requiring Guided Bone Regeneration (GBR) to facilitate implant placement at 6 months.
Eligibility
Inclusion Criteria:
- Men and women over 18 years old or older
- Patients requiring Guided Bone Regeneration due to insufficient ridge width(≤5mm) to place dental implants, with sufficient vertical ridge height (≥9mm) from vital anatomical structures (the inferior alveolar nerve in the Mandible, or the sinus in the Maxilla)
- One or more teeth missing in posterior zone (Premolars, and Molars)
- Absence of active Periodontal disease
- Good level of oral hygiene (Plaque index <25%)
- Absence of systemic diseases that could influence the outcome of the therapy (Uncontrolled diabetes, osteoporosis, bisphosphonate medications)
- Non smokers or light smokers (<10 cigarettes per day)
- Informed consent signed
Exclusion Criteria:
- Patients with sufficient ridge width (>5 mm) and height (≥9mm) from vital anatomical structure) requiring no GBR to place dental implants
- Patients with severe horizontal and vertical defects requiring other surgical techniques.
- Long-term non-steroidal anti-inflammatory drug therapy (3months).
- Lactating females or currently pregnant women.
- Severe cognitive or psychiatric disorders.
- Unwillingness to return for follow-up examination.